<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37511206</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>14</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>14</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Computational Prediction of the Interaction of Ivermectin with Fibrinogen.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">11449</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms241411449</ELocationID><Abstract><AbstractText>Hypercoagulability and formation of extensive and difficult-to-lyse microclots are a hallmark of both acute COVID-19 and long COVID. Fibrinogen, when converted to fibrin, is responsible for clot formation, but abnormal structural and mechanical clot properties can lead to pathologic thrombosis. Recent experimental evidence suggests that the spike protein (SP) from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may directly bind to the blood coagulation factor fibrinogen and induce structurally abnormal blood clots with heightened proinflammatory activity. Accordingly, in this study, we used molecular docking and molecular dynamics simulations to explore the potential activity of the antiparasitic drug ivermectin (IVM) to prevent the binding of the SARS-CoV-2 SP to fibrinogen and reduce the occurrence of microclots. Our computational results indicate that IVM may bind with high affinity to multiple sites on the fibrinogen peptide, with binding more likely in the central, E region, and in the coiled-coil region, as opposed to the globular D region. Taken together, our in silico results suggest that IVM may interfere with SP-fibrinogen binding and, potentially, decrease the formation of fibrin clots resistant to degradation. Additional in vitro studies are warranted to validate whether IVM binding to fibrinogen is sufficiently stable to prevent interaction with the SP, and potentially reduce its thrombo-inflammatory effect in vivo.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vottero</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University of Alberta, Edmonton, AB T6G 1Z2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tavernini</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Mechanical Engineering, University of Alberta, Edmonton, AB T6G 1H9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santin</LastName><ForeName>Alessandro D</ForeName><Initials>AD</Initials><Identifier Source="ORCID">0000-0003-4724-9738</Identifier><AffiliationInfo><Affiliation>Obstetrics, Gynecology &amp; Reproductive Sciences, Yale School of Medicine, P.O. Box 208063, New Haven, CT 06520-8063, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheim</LastName><ForeName>David E</ForeName><Initials>DE</Initials><Identifier Source="ORCID">0000-0001-6841-7054</Identifier><AffiliationInfo><Affiliation>US Public Health Service, Commissioned Corps, Inactive Reserve, Blacksburg, VA 24060-6367, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tuszynski</LastName><ForeName>Jack A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0001-9976-0429</Identifier><AffiliationInfo><Affiliation>Department of Physics, University of Alberta, Edmonton, AB T6G 1Z2, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DIMEAS, Politecnico di Torino, 10129 Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Data Science and Engineering, The Silesian University of Technology, 44-100 Gliwice, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aminpour</LastName><ForeName>Maral</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University of Alberta, Edmonton, AB T6G 1Z2, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9001-31-4</RegistryNumber><NameOfSubstance UI="D005337">Fibrin</NameOfSubstance></Chemical><Chemical><RegistryNumber>9001-32-5</RegistryNumber><NameOfSubstance UI="D005340">Fibrinogen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006490">Hemostatics</NameOfSubstance></Chemical><Chemical><RegistryNumber>70288-86-7</RegistryNumber><NameOfSubstance UI="D007559">Ivermectin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005337" MajorTopicYN="N">Fibrin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005340" MajorTopicYN="Y">Fibrinogen</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006490" MajorTopicYN="N">Hemostatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007559" MajorTopicYN="Y">Ivermectin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062105" MajorTopicYN="N">Molecular Docking Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="Y">Thrombosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">docking</Keyword><Keyword MajorTopicYN="N">fibrinogen</Keyword><Keyword MajorTopicYN="N">ivermectin</Keyword><Keyword MajorTopicYN="N">microclots</Keyword><Keyword MajorTopicYN="N">molecular modeling</Keyword></KeywordList><CoiStatement>A.D.S. reports grants from PUMA, grants from IMMUNOMEDICS, grants from GILEAD, grants from SYNTHON, grants and personal fees from MERCK, grants from BOEHINGER-INGELHEIM, grants from GENENTECH, grants and personal fees from TESARO, and grants and personal fees from EISAI. The other authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>11</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>1</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37511206</ArticleId><ArticleId IdType="pmc">PMC10380762</ArticleId><ArticleId IdType="doi">10.3390/ijms241411449</ArticleId><ArticleId IdType="pii">ijms241411449</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Litvinov R.I., Pieters M., de Lange-Loots Z., Weisel J.W. Fibrinogen and Fibrin. In: Harris J.R., Marles-Wright J., editors. Macromolecular Protein Complexes III: Structure and Function. Springer International Publishing; Cham, Switzerland: 2021. pp. 471&#x2013;501.</Citation></Reference><Reference><Citation>Ryu J.K., Sozmen E.G., Dixit K., Montano M., Matsui Y., Liu Y., Helmy E., Deerinck T.J., Yan Z., Schuck R., et al. SARS-CoV-2 Spike Protein Induces Abnormal Inflammatory Blood Clots Neutralized by Fibrin Immunotherapy. bioRxiv. 2021 doi: 10.1101/2021.10.12.464152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.10.12.464152</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogata A.F., Maley A.M., Wu C., Gilboa T., Norman M., Lazarovits R., Mao C.P., Newton G., Chang M., Nguyen K., et al. Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease. Clin. Chem. 2020;66:1562&#x2013;1572. doi: 10.1093/clinchem/hvaa213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinchem/hvaa213</ArticleId><ArticleId IdType="pmc">PMC7499543</ArticleId><ArticleId IdType="pubmed">32897389</ArticleId></ArticleIdList></Reference><Reference><Citation>Craddock V., Mahajan A., Spikes L., Krishnamachary B., Ram A.K., Kumar A., Chen L., Chalise P., Dhillon N.K. Persistent Circulation of Soluble and Extracellular Vesicle-Linked Spike Protein in Individuals with Postacute Sequelae of COVID-19. J. Med. Virol. 2023;95:e28568. doi: 10.1002/jmv.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28568</ArticleId><ArticleId IdType="pmc">PMC10048846</ArticleId><ArticleId IdType="pubmed">36756925</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z., Senussi Y., Manickas-Hill Z., Yu X.G., Li J.Z., Alter G., Walt D.R. Persistent Circulating SARS-CoC-2 Spike Is Associated with Post-Acute COVID-19 Sequelae. Clin. Infect. Dis. 2022;2022:ciac722. doi: 10.1093/cid/ciac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson B.K., Francisco E.B., Yogendra R., Long E., Pise A., Rodrigues H., Hall E., Herrera M., Parikh P., Guevara-Coto J., et al. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection. Front. Immunol. 2022;12:746021. doi: 10.3389/fimmu.2021.746021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746021</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A Clinical Case Definition of Post-COVID-19 Condition by a Delphi Consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M.W., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di Vincenzo J.D., Cao B., et al. Fatigue and Cognitive Impairment in Post-COVID-19 Syndrome: A Systematic Review and Meta-Analysis. Brain Behav. Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Aminpour M., Cannariato M., Preto J., Safaeeardebili M.E., Moracchiato A., Doria D., Donato F., Zizzi E.A., Deriu M.A., Scheim D.E., et al. In Silico Analysis of the Multi-Targeted Mode of Action of Ivermectin and Related Compounds. Computation. 2022;10:51. doi: 10.3390/computation10040051.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/computation10040051</ArticleId></ArticleIdList></Reference><Reference><Citation>Kollman J.M., Pandi L., Sawaya M.R., Riley M., Doolittle R.F. Crystal Structure of Human Fibrinogen. Biochemistry. 2009;48:3877&#x2013;3886. doi: 10.1021/bi802205g.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi802205g</ArticleId><ArticleId IdType="pubmed">19296670</ArticleId></ArticleIdList></Reference><Reference><Citation>Klykov O., van der Zwaan C., Heck A.J.R., Meijer A.B., Scheltema R.A. Missing Regions within the Molecular Architecture of Human Fibrin Clots Structurally Resolved by XL-MS and Integrative Structural Modeling. Proc. Natl. Acad. Sci. USA. 2020;117:1976&#x2013;1987. doi: 10.1073/pnas.1911785117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1911785117</ArticleId><ArticleId IdType="pmc">PMC6995014</ArticleId><ArticleId IdType="pubmed">31924745</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhmurov A., Protopopova A.D., Litvinov R.I., Zhukov P., Weisel J.W., Barsegov V. Atomic Structural Models of Fibrin Oligomers. Structure. 2018;26:857&#x2013;868.e4. doi: 10.1016/j.str.2018.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2018.04.005</ArticleId><ArticleId IdType="pmc">PMC6501597</ArticleId><ArticleId IdType="pubmed">29754827</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisel J.W. The Mechanical Properties of Fibrin for Basic Scientists and Clinicians. Biophys. Chem. 2004;112:267&#x2013;276. doi: 10.1016/j.bpc.2004.07.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpc.2004.07.029</ArticleId><ArticleId IdType="pubmed">15572258</ArticleId></ArticleIdList></Reference><Reference><Citation>Wygrecka M., Birnhuber A., Seeliger B., Michalick L., Pak O., Schultz A.-S., Schramm F., Zacharias M., Gorkiewicz G., David S., et al. Altered Fibrin Clot Structure and Dysregulated Fibrinolysis Contribute to Thrombosis Risk in Severe COVID-19. Blood Adv. 2022;6:1074&#x2013;1087. doi: 10.1182/bloodadvances.2021004816.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2021004816</ArticleId><ArticleId IdType="pmc">PMC8648369</ArticleId><ArticleId IdType="pubmed">34861681</ArticleId></ArticleIdList></Reference><Reference><Citation>Asakura H., Ogawa H. COVID-19-Associated Coagulopathy and Disseminated Intravascular Coagulation. Int. J. Hematol. 2021;113:45&#x2013;57. doi: 10.1007/s12185-020-03029-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12185-020-03029-y</ArticleId><ArticleId IdType="pmc">PMC7648664</ArticleId><ArticleId IdType="pubmed">33161508</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M., Thachil J., Iba T., Levy J.H. Coagulation Abnormalities and Thrombosis in Patients with COVID-19. Lancet Haematol. 2020;7:e438&#x2013;e440. doi: 10.1016/S2352-3026(20)30145-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30145-9</ArticleId><ArticleId IdType="pmc">PMC7213964</ArticleId><ArticleId IdType="pubmed">32407672</ArticleId></ArticleIdList></Reference><Reference><Citation>Wool G.D., Miller J.L. The Impact of COVID-19 Disease on Platelets and Coagulation. Pathobiology. 2021;88:15&#x2013;27. doi: 10.1159/000512007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000512007</ArticleId><ArticleId IdType="pmc">PMC7649697</ArticleId><ArticleId IdType="pubmed">33049751</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Venter C., Laubscher G.J., Lourens P.J., Steenkamp J., Kell D.B. Prevalence of Readily Detected Amyloid Blood Clots in &#x2018;Unclotted&#x2019; Type 2 Diabetes Mellitus and COVID-19 Plasma: A Preliminary Report. Cardiovasc. Diabetol. 2020;19:193. doi: 10.1186/s12933-020-01165-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-020-01165-7</ArticleId><ArticleId IdType="pmc">PMC7670290</ArticleId><ArticleId IdType="pubmed">33203441</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Venter C., Laubscher G.J., Kotze M.J., Oladejo S.O., Watson L.R., Rajaratnam K., Watson B.W., Kell D.B. Prevalence of Symptoms, Comorbidities, Fibrin Amyloid Microclots and Platelet Pathology in Individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC) Cardiovasc. Diabetol. 2022;21:148. doi: 10.1186/s12933-022-01579-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01579-5</ArticleId><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Picken M.M. Fibrinogen Amyloidosis: The Clot Thickens! Blood. 2010;115:2985&#x2013;2986. doi: 10.1182/blood-2009-12-236810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2009-12-236810</ArticleId><ArticleId IdType="pubmed">20395420</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Laubscher G.J., Pretorius E. A Central Role for Amyloid Fibrin Microclots in Long COVID/PASC: Origins and Therapeutic Implications. Biochem. J. 2022;479:537&#x2013;559. doi: 10.1042/BCJ20220016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220016</ArticleId><ArticleId IdType="pmc">PMC8883497</ArticleId><ArticleId IdType="pubmed">35195253</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobbelaar L.M., Venter C., Vlok M., Ngoepe M., Laubscher G.J., Lourens P.J., Steenkamp J., Kell D.B., Pretorius E. SARS-CoV-2 Spike Protein S1 Induces Fibrin(Ogen) Resistant to Fibrinolysis: Implications for Microclot Formation in COVID-19. Biosci. Rep. 2021;41:BSR20210611. doi: 10.1042/BSR20210611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20210611</ArticleId><ArticleId IdType="pmc">PMC8380922</ArticleId><ArticleId IdType="pubmed">34328172</ArticleId></ArticleIdList></Reference><Reference><Citation>Davalos D., Akassoglou K. Fibrinogen as a Key Regulator of Inflammation in Disease. Semin. Immunopathol. 2012;34:43&#x2013;62. doi: 10.1007/s00281-011-0290-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-011-0290-8</ArticleId><ArticleId IdType="pubmed">22037947</ArticleId></ArticleIdList></Reference><Reference><Citation>Bullard D.C. Chapter 41&#x2014;CR3. In: Barnum S., Schein T., editors. The Complement FactsBook. 2nd ed. Academic Press; Cambridge, MA, USA: 2018. pp. 435&#x2013;450.</Citation></Reference><Reference><Citation>Crump A. Ivermectin: Enigmatic Multifaceted &#x201c;wonder&#x201d; Drug Continues to Surprise and Exceed Expectations. J. Antibiot. 2017;70:495&#x2013;505. doi: 10.1038/ja.2017.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ja.2017.11</ArticleId><ArticleId IdType="pubmed">28196978</ArticleId></ArticleIdList></Reference><Reference><Citation>Molyneux D.H., Ward S.A. Reflections on the Nobel Prize for Medicine 2015&#x2014;The Public Health Legacy and Impact of Avermectin and Artemisinin. Trends Parasitol. 2015;31:605&#x2013;607. doi: 10.1016/j.pt.2015.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pt.2015.10.008</ArticleId><ArticleId IdType="pubmed">26552892</ArticleId></ArticleIdList></Reference><Reference><Citation>Santin A.D., Scheim D.E., McCullough P.A., Yagisawa M., Borody T.J. Ivermectin: A Multifaceted Drug of Nobel Prize-Honored Distinction with Indicated Efficacy against a New Global Scourge, COVID-19. New Microbes New Infect. 2021;43:100924. doi: 10.1016/j.nmni.2021.100924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmni.2021.100924</ArticleId><ArticleId IdType="pmc">PMC8383101</ArticleId><ArticleId IdType="pubmed">34466270</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzzo C.A., Furtek C.I., Porras A.G., Chen C., Tipping R., Clineschmidt C.M., Sciberras D.G., Hsieh J.Y., Lasseter K.C. Safety, Tolerability, and Pharmacokinetics of Escalating High Doses of Ivermectin in Healthy Adult Subjects. J. Clin. Pharmacol. 2002;42:1122&#x2013;1133. doi: 10.1177/009127002237994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/009127002237994</ArticleId><ArticleId IdType="pubmed">12362927</ArticleId></ArticleIdList></Reference><Reference><Citation>Navarro M., Camprub&#xed; D., Requena-M&#xe9;ndez A., Buonfrate D., Giorli G., Kamgno J., Gardon J., Boussinesq M., Mu&#xf1;oz J., Krolewiecki A. Safety of High-Dose Ivermectin: A Systematic Review and Meta-Analysis. J. Antimicrob. Chemother. 2020;75:827&#x2013;834. doi: 10.1093/jac/dkz524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkz524</ArticleId><ArticleId IdType="pubmed">31960060</ArticleId></ArticleIdList></Reference><Reference><Citation>Nobel Prize Committee . The 2015 Nobel Prize in Physiology or Medicine&#x2014;Press Release, 5 October 2015. The Nobel Assembly at Karolinska Institutet; Solna, Sweden: 2015.</Citation></Reference><Reference><Citation>Molecular Operating Environment (MOE) 2022.02. Chemical Computing Group ULC; 910-1010 Sherbrooke St. W., Montreal, QC H3A 2R7, Canada: 2023.</Citation></Reference><Reference><Citation>Yakovlev S., Gorlatov S., Ingham K., Medved L. Interaction of Fibrin(Ogen) with Heparin: Further Characterization and Localization of the Heparin-Binding Site. Biochemistry. 2003;42:7709&#x2013;7716. doi: 10.1021/bi0344073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi0344073</ArticleId><ArticleId IdType="pubmed">12820880</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Duan H., Song Z., Xu R. Comparative Study on the Interaction between Fibrinogen and Flavonoids. J. Mol. Struct. 2022;1262:132963. doi: 10.1016/j.molstruc.2022.132963.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molstruc.2022.132963</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafreen R.M., Lakshmi S.A., Pandian S.K., Park Y.S., Kim Y.M., Pa&#x15b;ko P., Deutsch J., Katrich E., Gorinstein S. Unraveling the Antioxidant, Binding and Health-Protecting Properties of Phenolic Compounds of Beers with Main Human Serum Proteins: In Vitro and In Silico Approaches. Molecules. 2020;25:4962. doi: 10.3390/molecules25214962.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25214962</ArticleId><ArticleId IdType="pmc">PMC7663678</ArticleId><ArticleId IdType="pubmed">33120936</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Tang X., Pei J., Zhang L., Liu F., Li K. Gastrodin Interaction with Human Fibrinogen: Anticoagulant Effects and Binding Studies. Chem. Eur. J. 2006;12:7807&#x2013;7815. doi: 10.1002/chem.200600549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/chem.200600549</ArticleId><ArticleId IdType="pubmed">16847996</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Durruthy M., Scanavachi G., Rial R., Liu Z., Cordeiro M.N.D.S., Itri R., Ruso J.M. Mapping the Underlying Mechanisms of Fibrinogen Benzothiazole Drug Interactions Using Computational and Experimental Approaches. Int. J. Biol. Macromol. 2020;163:730&#x2013;744. doi: 10.1016/j.ijbiomac.2020.07.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2020.07.044</ArticleId><ArticleId IdType="pubmed">32653381</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Durruthy M., Rial R., Cordeiro M.N.D.S., Liu Z., Ruso J.M. Exploring the Conformational Binding Mechanism of Fibrinogen Induced by Interactions with Penicillin &#x3b2;-Lactam Antibiotic Drugs. J. Mol. Liq. 2021;324:114667. doi: 10.1016/j.molliq.2020.114667.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molliq.2020.114667</ArticleId></ArticleIdList></Reference><Reference><Citation>Stubbs M.T., Oschkinat H., Mayr I., Huber R., Angliker H., Stone S.R., Bode W. The Interaction of Thrombin with Fibrinogen. A structural basis for its specificity. Eur. J. Biochem. 1992;206:187&#x2013;195. doi: 10.1111/j.1432-1033.1992.tb16916.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1432-1033.1992.tb16916.x</ArticleId><ArticleId IdType="pubmed">1587268</ArticleId></ArticleIdList></Reference><Reference><Citation>Syahbanu F., Giriwono P.E., Tjandrawinata R.R., Suhartono M.T. Molecular Docking of Subtilisin K2, a Fibrin-Degrading Enzyme from Indonesian Moromi, with Its Substrates. Food Sci. Technol. 2022;42:e61820. doi: 10.1590/fst.61820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/fst.61820</ArticleId></ArticleIdList></Reference><Reference><Citation>DrugBank Compound Summary for Ivermectin.  [(accessed on 23 March 2023)].  Available online:  https://go.drugbank.com/drugs/DB00602.</Citation></Reference><Reference><Citation>Schneidman-Duhovny D., Inbar Y., Nussinov R., Wolfson H.J. PatchDock and SymmDock: Servers for Rigid and Symmetric Docking. Nucleic Acids Res. 2005;33:W363&#x2013;W367. doi: 10.1093/nar/gki481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gki481</ArticleId><ArticleId IdType="pmc">PMC1160241</ArticleId><ArticleId IdType="pubmed">15980490</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrusier N., Nussinov R., Wolfson H.J. FireDock: Fast Interaction Refinement in Molecular Docking. Proteins. 2007;69:139&#x2013;159. doi: 10.1002/prot.21495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.21495</ArticleId><ArticleId IdType="pubmed">17598144</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheim D.E. A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody. Int. J. Mol. Sci. 2022;23:2558. doi: 10.3390/ijms23052558.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23052558</ArticleId><ArticleId IdType="pmc">PMC8910562</ArticleId><ArticleId IdType="pubmed">35269703</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin-Frankel J. The Mystery of the Pandemic&#x2019;s &#x2018;Happy Hypoxia&#x2019;. Science. 2020;368:455&#x2013;456. doi: 10.1126/science.368.6490.455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.368.6490.455</ArticleId><ArticleId IdType="pubmed">32355007</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapkiewicz A.V., Mai X., Carsons S.E., Pittaluga S., Kleiner D.E., Berger J.S., Thomas S., Adler N.M., Charytan D.M., Gasmi B., et al. Megakaryocytes and Platelet-Fibrin Thrombi Characterize Multi-Organ Thrombosis at Autopsy in COVID-19: A Case Series. EClinicalMedicine. 2020;24:100434. doi: 10.1016/j.eclinm.2020.100434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100434</ArticleId><ArticleId IdType="pmc">PMC7316051</ArticleId><ArticleId IdType="pubmed">32766543</ArticleId></ArticleIdList></Reference><Reference><Citation>Price L.C., McCabe C., Garfield B., Wort S.J. Thrombosis and COVID-19 Pneumonia: The Clot Thickens! Eur. Respir. J. 2020;56:2001608. doi: 10.1183/13993003.01608-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01608-2020</ArticleId><ArticleId IdType="pmc">PMC7301830</ArticleId><ArticleId IdType="pubmed">32554532</ArticleId></ArticleIdList></Reference><Reference><Citation>Huertas A., Montani D., Savale L., Pichon J., Tu L., Parent F., Guignabert C., Humbert M. Endothelial Cell Dysfunction: A Major Player in SARS-CoV-2 Infection (COVID-19)? Eur. Respir. J. 2020;56:2001634. doi: 10.1183/13993003.01634-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01634-2020</ArticleId><ArticleId IdType="pmc">PMC7301835</ArticleId><ArticleId IdType="pubmed">32554538</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Sehrawat T.S., Bikdeli B., Ahluwalia N., Ausiello J.C., Wan E.Y., et al. Extrapulmonary Manifestations of COVID-19. Nat. Med. 2020;26:1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker R.C. COVID-19 Update: COVID-19-Associated Coagulopathy. J. Thromb. Thrombolysis. 2020;50:54&#x2013;67. doi: 10.1007/s11239-020-02134-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-020-02134-3</ArticleId><ArticleId IdType="pmc">PMC7225095</ArticleId><ArticleId IdType="pubmed">32415579</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondal R., Lahiri D., Deb S., Bandyopadhyay D., Shome G., Sarkar S., Paria S.R., Thakurta T.G., Singla P., Biswas S.C. COVID-19: Are We Dealing with a Multisystem Vasculopathy in Disguise of a Viral Infection? J. Thromb. Thrombolysis. 2020;50:567&#x2013;579. doi: 10.1007/s11239-020-02210-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-020-02210-8</ArticleId><ArticleId IdType="pmc">PMC7335630</ArticleId><ArticleId IdType="pubmed">32627126</ArticleId></ArticleIdList></Reference><Reference><Citation>Magro C., Mulvey J.J., Berlin D., Nuovo G., Salvatore S., Harp J., Baxter-Stoltzfus A., Laurence J. Complement Associated Microvascular Injury and Thrombosis in the Pathogenesis of Severe COVID-19 Infection: A Report of Five Cases. Transl. Res. 2020;220:1&#x2013;13. doi: 10.1016/j.trsl.2020.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2020.04.007</ArticleId><ArticleId IdType="pmc">PMC7158248</ArticleId><ArticleId IdType="pubmed">32299776</ArticleId></ArticleIdList></Reference><Reference><Citation>Menter T., Haslbauer J.D., Nienhold R., Savic S., Hopfer H., Deigendesch N., Frank S., Turek D., Willi N., Pargger H., et al. Postmortem Examination of COVID-19 Patients Reveals Diffuse Alveolar Damage with Severe Capillary Congestion and Variegated Findings in Lungs and Other Organs Suggesting Vascular Dysfunction. Histopathology. 2020;77:198&#x2013;209. doi: 10.1111/his.14134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/his.14134</ArticleId><ArticleId IdType="pmc">PMC7496150</ArticleId><ArticleId IdType="pubmed">32364264</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattinoni L., Coppola S., Cressoni M., Busana M., Rossi S., Chiumello D. COVID-19 Does Not Lead to a &#x201c;Typical&#x201d; Acute Respiratory Distress Syndrome. Am. J. Respir. Crit. Care Med. 2020;201:1299&#x2013;1300. doi: 10.1164/rccm.202003-0817LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202003-0817LE</ArticleId><ArticleId IdType="pmc">PMC7233352</ArticleId><ArticleId IdType="pubmed">32228035</ArticleId></ArticleIdList></Reference><Reference><Citation>Marini J.J., Gattinoni L. Management of COVID-19 Respiratory Distress. JAMA. 2020;323:2329&#x2013;2330. doi: 10.1001/jama.2020.6825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6825</ArticleId><ArticleId IdType="pubmed">32329799</ArticleId></ArticleIdList></Reference><Reference><Citation>Berzuini A., Bianco C., Migliorini A.C., Maggioni M., Valenti L., Prati D. Red Blood Cell Morphology in Patients with COVID-19-Related Anaemia. Blood Transfus. 2021;19:34&#x2013;36. doi: 10.2450/2020.0242-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.2450/2020.0242-20</ArticleId><ArticleId IdType="pmc">PMC7850925</ArticleId><ArticleId IdType="pubmed">32955421</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakhdari N., Tabet B., Boudraham L., Laoussati M., Aissanou S., Beddou L., Bensalem S., Bellik Y., Bournine L., Fatmi S., et al. Red Blood Cells Injuries and Hypersegmented Neutrophils in COVID-19 Peripheral Blood Film. medRxiv. 2020 doi: 10.1101/2020.07.24.20160101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.24.20160101</ArticleId></ArticleIdList></Reference><Reference><Citation>Melkumyants A., Buryachkovskaya L., Lomakin N., Antonova O., Serebruany V. Mild COVID-19 and Impaired Blood Cell&#x2013;Endothelial Crosstalk: Considering Long-Term Use of Antithrombotics? Thromb. Haemost. 2022;122:123&#x2013;130. doi: 10.1055/a-1551-9911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1551-9911</ArticleId><ArticleId IdType="pubmed">34482535</ArticleId></ArticleIdList></Reference><Reference><Citation>Kibria F., Hysi E., Strohm E.M., Kolios M.C. Identification of Red Blood Cell Rouleaux Formation Using Photoacoustic Ultrasound Spectroscopy; Proceedings of the Photons Plus Ultrasound: Imaging and Sensing 2014; San Francisco, CA, USA. 1&#x2013;6 February 2014; p. 894367.</Citation></Reference><Reference><Citation>Hysi E., Saha R.K., Kolios M.C. Photoacoustic Ultrasound Spectroscopy for Assessing Red Blood Cell Aggregation and Oxygenation. J. Biomed. Opt. 2012;17:125006. doi: 10.1117/1.JBO.17.12.125006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1117/1.JBO.17.12.125006</ArticleId><ArticleId IdType="pubmed">23235833</ArticleId></ArticleIdList></Reference><Reference><Citation>Boschi C., Scheim D.E., Bancod A., Militello M., Bideau M.L., Colson P., Fantini J., Scola B.L. SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects. Int. J. Mol. Sci. 2022;23:15480. doi: 10.3390/ijms232415480.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232415480</ArticleId><ArticleId IdType="pmc">PMC9779393</ArticleId><ArticleId IdType="pubmed">36555121</ArticleId></ArticleIdList></Reference><Reference><Citation>Barshtein G., Wajnblum D., Yedgar S. Kinetics of Linear Rouleaux Formation Studied by Visual Monitoring of Red Cell Dynamic Organization. Biophys. J. 2000;78:2470&#x2013;2474. doi: 10.1016/S0006-3495(00)76791-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-3495(00)76791-9</ArticleId><ArticleId IdType="pmc">PMC1300836</ArticleId><ArticleId IdType="pubmed">10777743</ArticleId></ArticleIdList></Reference><Reference><Citation>Baskurt O.K., Meiselman H.J. Erythrocyte Aggregation: Basic Aspects and Clinical Importance. Clin. Hemorheol. Microcirc. 2013;53:23&#x2013;37. doi: 10.3233/CH-2012-1573.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-2012-1573</ArticleId><ArticleId IdType="pubmed">22975932</ArticleId></ArticleIdList></Reference><Reference><Citation>Meiselman H.J. Red Blood Cell Aggregation: 45 Years Being Curious. Biorheology. 2009;46:1&#x2013;19. doi: 10.3233/BIR-2009-0522.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/BIR-2009-0522</ArticleId><ArticleId IdType="pubmed">19252224</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner C., Steffen P., Svetina S. Aggregation of Red Blood Cells: From Rouleaux to Clot Formation. Comptes Rendus Phys. 2013;14:459&#x2013;469. doi: 10.1016/j.crhy.2013.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crhy.2013.04.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabioni L., De Lorenzo A., Lamas C., Muccillo F., Castro-Faria-Neto H.C., Estato V., Tibirica E. Systemic Microvascular Endothelial Dysfunction and Disease Severity in COVID-19 Patients: Evaluation by Laser Doppler Perfusion Monitoring and Cytokine/Chemokine Analysis. Microvasc. Res. 2021;134:104119. doi: 10.1016/j.mvr.2020.104119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2020.104119</ArticleId><ArticleId IdType="pmc">PMC7710468</ArticleId><ArticleId IdType="pubmed">33278457</ArticleId></ArticleIdList></Reference><Reference><Citation>Biondi M.A.X., Gulati M., Possick J., Joseph P., Singh I., Lutchmansingh D. Unexplained dyspnea in a patient with a history of COVID-19. Chest. 2021;160:A2373&#x2013;A2374. doi: 10.1016/j.chest.2021.07.2054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.07.2054</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I., Joseph P., Heerdt P.M., Cullinan M., Lutchmansingh D.D., Gulati M., Possick J.D., Systrom D.M., Waxman A.B. Persistent Exertional Intolerance After COVID-19: Insights from Invasive Cardiopulmonary Exercise Testing. Chest. 2022;161:54&#x2013;63. doi: 10.1016/j.chest.2021.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.08.010</ArticleId><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Klotz U., Ogbuokiri J.E., Okonkwo P.O. Ivermectin Binds Avidly to Plasma Proteins. Eur. J. Clin. Pharmacol. 1990;39:607&#x2013;608. doi: 10.1007/BF00316107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00316107</ArticleId><ArticleId IdType="pubmed">2095348</ArticleId></ArticleIdList></Reference><Reference><Citation>Edelsbrunner H., Kirkpatrick D., Seidel R. On the Shape of a Set of Points in the Plane. IEEE Trans. Inf. Theory. 1983;29:551&#x2013;559. doi: 10.1109/TIT.1983.1056714.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TIT.1983.1056714</ArticleId></ArticleIdList></Reference><Reference><Citation>Soga S., Shirai H., Kobori M., Hirayama N. Use of Amino Acid Composition to Predict Ligand-Binding Sites. J. Chem. Inf. Model. 2007;47:400&#x2013;406. doi: 10.1021/ci6002202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci6002202</ArticleId><ArticleId IdType="pubmed">17243757</ArticleId></ArticleIdList></Reference><Reference><Citation>Vald&#xe9;s-Tresanco M.S., Vald&#xe9;s-Tresanco M.E., Valiente P.A., Moreno E. AMDock: A Versatile Graphical Tool for Assisting Molecular Docking with Autodock Vina and Autodock4. Biol. Direct. 2020;15:12. doi: 10.1186/s13062-020-00267-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13062-020-00267-2</ArticleId><ArticleId IdType="pmc">PMC7493944</ArticleId><ArticleId IdType="pubmed">32938494</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Boyle N.M., Banck M., James C.A., Morley C., Vandermeersch T., Hutchison G.R. Open Babel: An Open Chemical Toolbox. J. Cheminform. 2011;3:33. doi: 10.1186/1758-2946-3-33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1758-2946-3-33</ArticleId><ArticleId IdType="pmc">PMC3198950</ArticleId><ArticleId IdType="pubmed">21982300</ArticleId></ArticleIdList></Reference><Reference><Citation>Eberhardt J., Santos-Martins D., Tillack A.F., Forli S. AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings. J. Chem. Inf. Model. 2021;61:3891&#x2013;3898. doi: 10.1021/acs.jcim.1c00203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.1c00203</ArticleId><ArticleId IdType="pmc">PMC10683950</ArticleId><ArticleId IdType="pubmed">34278794</ArticleId></ArticleIdList></Reference><Reference><Citation>Preto J., Gentile F. Assessing and improving the performance of consensus docking strategies using the DockBox package. J Comput. Aided Mol. Des. 2019;33:817&#x2013;829. doi: 10.1007/s10822-019-00227-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10822-019-00227-7</ArticleId><ArticleId IdType="pubmed">31578656</ArticleId></ArticleIdList></Reference><Reference><Citation>Darden T.A., Duke R.E., Giambasu G., Gilson M.K., Gohlke H., Goetz A.W., Harris R., Izadi S., Izmailov S.A., Kasavajhala K., et al.  AMBER 2020.  [(accessed on 15 June 2023)].  Available online:  http://ambermd.org/</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>